Table 3

Long-term assessment of patients with ALPS-related symptoms present < 15 years and with a follow-up of > 20 years (N = 42)

Less than 15 years, n (%)*More than 20 years, n (%)
Lymphoproliferation 42 (100) Complete remission 28 (66) 
 Improvement 14 (34) 
Autoimmunity 25 (59) Complete remission 11 (44) 
 Persistent 14 (56) 
Treatment 26 (48) Stopped 12 (46) 
 Persistent 14 (54) 
Less than 15 years, n (%)*More than 20 years, n (%)
Lymphoproliferation 42 (100) Complete remission 28 (66) 
 Improvement 14 (34) 
Autoimmunity 25 (59) Complete remission 11 (44) 
 Persistent 14 (56) 
Treatment 26 (48) Stopped 12 (46) 
 Persistent 14 (54) 
*

Median age at onset, 3 y (range: 0-14).

Median follow-up time, 28 y (range: 20.5-77).

Close Modal

or Create an Account

Close Modal
Close Modal